
Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. Patients using inhaled insulin (Afrezza) plus long-lasting insulin degludec injections had better control over their blood sugar than those assigned to receive usual care, researchers report. About 21% of those on inhaled… read on > read on >